| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/05/2004 | CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 09/30/2004 | WO2004083231A2 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004082683A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | WO2004082668A1 Coenzyme q10-containing proliposome and preparation thereof |
| 09/30/2004 | WO2004082642A1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 09/30/2004 | WO2004082583A2 Use of oligogalacturonides in cosmetics or for the preparation of a dermatological or pharmaceutical composition |
| 09/30/2004 | WO2004066969A3 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same |
| 09/30/2004 | WO2004062659A8 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |
| 09/30/2004 | WO2004043331A3 Dermastick thickened ointment |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192949 Solvent extraction using free radical scavenger; isolation |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192908 Human and veterinary medicine; drugs, cosmetics ; prevention therapy dyslipidemia; cardiovascular disorders; antidiabetic agents; obesity; hypotensive agents; antiaging agents; anticancer agents |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192785 Inhibition of TNF-alpha-initiated neutrophil response |
| 09/30/2004 | US20040192756 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the opthalmic field |
| 09/30/2004 | US20040192754 Administering serotonin inhibitors; such as ketanserin, ritanserin, mainserin, cyproheptadine, fluoxetine, olanzapine, ziprasidone |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents |
| 09/30/2004 | US20040192689 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192662 Topically administering tazarotene gel and corticoid cream |
| 09/30/2004 | US20040192606 treating an infection or ischemic wound in a mammal by administering relaxin; treating ischemic ulcer with recombinant human relaxin (H2) for example |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders |
| 09/30/2004 | US20040191311 Use of methyltestosterone as a drug for treatment of human papilloma virus infections |
| 09/30/2004 | US20040191282 Hemectant and cosmetics and internal preparations containing the same |
| 09/30/2004 | US20040191278 Enhancing dermal collagen production; wrinkle treatment; vasodilation with nicotinic acid and irradiation |
| 09/30/2004 | US20040191234 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/30/2004 | US20040191231 Medicinal product for the promotion of wound healing |
| 09/30/2004 | US20040191219 HSA-free formulations of interferon-beta |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191206 Methods for reduction of inflammation and erythema |
| 09/30/2004 | US20040191203 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 09/30/2004 | US20040191190 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 09/30/2004 | US20040191171 Method of detecting skin stimulation effect |
| 09/30/2004 | US20040187230 Quaternized celluloses and quaternized hydroxyethylcelluloses or quaternized polyamines celluloses for hair dyes |
| 09/30/2004 | CA2633287A1 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases |
| 09/30/2004 | CA2519026A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | CA2518709A1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
| 09/29/2004 | EP1462109A1 Hemostatic, emollient and lubricating preparations containing pork fat extract (lard) |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1462081A1 Ceramide emulsions |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461347A1 2-o-(-d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461086A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 09/29/2004 | EP1461072A1 Proteases producing an altered immunological response and methods of making and using the same |
| 09/29/2004 | EP1461060A2 Cosmetic composition containing an oil extracted for murumuru seeds |
| 09/29/2004 | EP1461059A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 09/29/2004 | EP1461057A1 A topical anti-itch formulation and a process for the preparation thereof |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461053A2 Storage-stable fibrin sealant |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461032A2 Use of tyrosine kinase inhibitors for promoting hair growth |
| 09/29/2004 | EP1461024A1 Treatment of wounds and compositions employed |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1282394B1 Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1003526B1 Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | EP0983080B1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/29/2004 | EP0928789B1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same |
| 09/29/2004 | EP0828501B1 Extract from the leaves of ginkgo biloba |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |